Cargando…

Genetic biomarkers of sensitivity and resistance to venetoclax monotherapy in patients with relapsed acute myeloid leukemia

Detalles Bibliográficos
Autores principales: Chyla, Brenda, Daver, Naval, Doyle, Kelly, McKeegan, Evelyn, Huang, Xin, Ruvolo, Vivian, Wang, Zixing, Chen, Ken, Souers, Andrew, Leverson, Joel, Potluri, Jalaja, Boghaert, Erwin, Bhathena, Anahita, Konopleva, Marina, Popovic, Relja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120451/
https://www.ncbi.nlm.nih.gov/pubmed/29770480
http://dx.doi.org/10.1002/ajh.25146
_version_ 1783352271789096960
author Chyla, Brenda
Daver, Naval
Doyle, Kelly
McKeegan, Evelyn
Huang, Xin
Ruvolo, Vivian
Wang, Zixing
Chen, Ken
Souers, Andrew
Leverson, Joel
Potluri, Jalaja
Boghaert, Erwin
Bhathena, Anahita
Konopleva, Marina
Popovic, Relja
author_facet Chyla, Brenda
Daver, Naval
Doyle, Kelly
McKeegan, Evelyn
Huang, Xin
Ruvolo, Vivian
Wang, Zixing
Chen, Ken
Souers, Andrew
Leverson, Joel
Potluri, Jalaja
Boghaert, Erwin
Bhathena, Anahita
Konopleva, Marina
Popovic, Relja
author_sort Chyla, Brenda
collection PubMed
description
format Online
Article
Text
id pubmed-6120451
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-61204512018-09-05 Genetic biomarkers of sensitivity and resistance to venetoclax monotherapy in patients with relapsed acute myeloid leukemia Chyla, Brenda Daver, Naval Doyle, Kelly McKeegan, Evelyn Huang, Xin Ruvolo, Vivian Wang, Zixing Chen, Ken Souers, Andrew Leverson, Joel Potluri, Jalaja Boghaert, Erwin Bhathena, Anahita Konopleva, Marina Popovic, Relja Am J Hematol E‐only Articles John Wiley and Sons Inc. 2018-08-16 2018-08 /pmc/articles/PMC6120451/ /pubmed/29770480 http://dx.doi.org/10.1002/ajh.25146 Text en © 2018 The Authors American Journal of Hematology Published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle E‐only Articles
Chyla, Brenda
Daver, Naval
Doyle, Kelly
McKeegan, Evelyn
Huang, Xin
Ruvolo, Vivian
Wang, Zixing
Chen, Ken
Souers, Andrew
Leverson, Joel
Potluri, Jalaja
Boghaert, Erwin
Bhathena, Anahita
Konopleva, Marina
Popovic, Relja
Genetic biomarkers of sensitivity and resistance to venetoclax monotherapy in patients with relapsed acute myeloid leukemia
title Genetic biomarkers of sensitivity and resistance to venetoclax monotherapy in patients with relapsed acute myeloid leukemia
title_full Genetic biomarkers of sensitivity and resistance to venetoclax monotherapy in patients with relapsed acute myeloid leukemia
title_fullStr Genetic biomarkers of sensitivity and resistance to venetoclax monotherapy in patients with relapsed acute myeloid leukemia
title_full_unstemmed Genetic biomarkers of sensitivity and resistance to venetoclax monotherapy in patients with relapsed acute myeloid leukemia
title_short Genetic biomarkers of sensitivity and resistance to venetoclax monotherapy in patients with relapsed acute myeloid leukemia
title_sort genetic biomarkers of sensitivity and resistance to venetoclax monotherapy in patients with relapsed acute myeloid leukemia
topic E‐only Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120451/
https://www.ncbi.nlm.nih.gov/pubmed/29770480
http://dx.doi.org/10.1002/ajh.25146
work_keys_str_mv AT chylabrenda geneticbiomarkersofsensitivityandresistancetovenetoclaxmonotherapyinpatientswithrelapsedacutemyeloidleukemia
AT davernaval geneticbiomarkersofsensitivityandresistancetovenetoclaxmonotherapyinpatientswithrelapsedacutemyeloidleukemia
AT doylekelly geneticbiomarkersofsensitivityandresistancetovenetoclaxmonotherapyinpatientswithrelapsedacutemyeloidleukemia
AT mckeeganevelyn geneticbiomarkersofsensitivityandresistancetovenetoclaxmonotherapyinpatientswithrelapsedacutemyeloidleukemia
AT huangxin geneticbiomarkersofsensitivityandresistancetovenetoclaxmonotherapyinpatientswithrelapsedacutemyeloidleukemia
AT ruvolovivian geneticbiomarkersofsensitivityandresistancetovenetoclaxmonotherapyinpatientswithrelapsedacutemyeloidleukemia
AT wangzixing geneticbiomarkersofsensitivityandresistancetovenetoclaxmonotherapyinpatientswithrelapsedacutemyeloidleukemia
AT chenken geneticbiomarkersofsensitivityandresistancetovenetoclaxmonotherapyinpatientswithrelapsedacutemyeloidleukemia
AT souersandrew geneticbiomarkersofsensitivityandresistancetovenetoclaxmonotherapyinpatientswithrelapsedacutemyeloidleukemia
AT leversonjoel geneticbiomarkersofsensitivityandresistancetovenetoclaxmonotherapyinpatientswithrelapsedacutemyeloidleukemia
AT potlurijalaja geneticbiomarkersofsensitivityandresistancetovenetoclaxmonotherapyinpatientswithrelapsedacutemyeloidleukemia
AT boghaerterwin geneticbiomarkersofsensitivityandresistancetovenetoclaxmonotherapyinpatientswithrelapsedacutemyeloidleukemia
AT bhathenaanahita geneticbiomarkersofsensitivityandresistancetovenetoclaxmonotherapyinpatientswithrelapsedacutemyeloidleukemia
AT konoplevamarina geneticbiomarkersofsensitivityandresistancetovenetoclaxmonotherapyinpatientswithrelapsedacutemyeloidleukemia
AT popovicrelja geneticbiomarkersofsensitivityandresistancetovenetoclaxmonotherapyinpatientswithrelapsedacutemyeloidleukemia